MoneyWorks4Me

Triochem Products - Quaterly Results

12 Feb 2025 Evaluate
A minor change in the total revenue was seen in the December 2024 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Total Profit for the quarter ended December 2024 of Rs. 0.89 millions grew from Rs.-2.04 millions Operating profit Margin for the quarter ended December 2024 improved to -1.30% as compared to -1.95% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 4.59 0.35 1211.43 9.56 2.27 321.15 10.30 2.78 270.50
PBIDT -1.30 -1.95 -33.33 -2.36 -5.56 -57.55 -0.83 -10.65 -92.21
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -1.30 -1.95 -33.33 -2.36 -17.13 -86.22 -12.40 -10.65 16.43
Depreciation 0.38 0.23 65.22 0.76 0.68 11.76 0.90 1.05 -14.29
PBT -1.68 -2.18 -22.94 -3.12 -17.81 -82.48 -13.30 -11.70 13.68
TAX -2.57 -0.14 1735.71 -2.87 -4.43 -35.21 -3.17 -2.85 11.23
Deferred Tax -0.34 -0.14 142.86 -0.64 -4.43 -85.55 -4.35 -2.76 57.61
PAT 0.89 -2.04 -143.63 -0.25 -13.38 -98.13 -10.13 -8.85 14.46
Equity 2.45 2.45 0.00 2.45 2.45 0.00 2.45 2.45 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..